Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Mycoplasma pneumoniae-associated mild encephalitis/encephalopathy with a reversible splenial lesion: report of two pediatric cases and a comprehensive literature review.

Identifieur interne : 000F67 ( PubMed/Checkpoint ); précédent : 000F66; suivant : 000F68

Mycoplasma pneumoniae-associated mild encephalitis/encephalopathy with a reversible splenial lesion: report of two pediatric cases and a comprehensive literature review.

Auteurs : Norishi Ueda [Japon] ; Satoshi Minami [Japon] ; Manabu Akimoto [Japon]

Source :

RBID : pubmed:27836006

Descripteurs français

English descriptors

Abstract

No literature review exists on Mycoplasma pneumoniae-associated mild encephalitis/encepharopathy with a reversible splenial lesion (MERS).

DOI: 10.1186/s12879-016-1985-1
PubMed: 27836006


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:27836006

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Mycoplasma pneumoniae-associated mild encephalitis/encephalopathy with a reversible splenial lesion: report of two pediatric cases and a comprehensive literature review.</title>
<author>
<name sortKey="Ueda, Norishi" sort="Ueda, Norishi" uniqKey="Ueda N" first="Norishi" last="Ueda">Norishi Ueda</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pediatrics, Public Central Hospital of Matto Ishikawa, 3-8 Kuramitsu, Hakusan, 924-8588, Ishikawa, Japan. nueda@mattohp.com.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Pediatrics, Public Central Hospital of Matto Ishikawa, 3-8 Kuramitsu, Hakusan, 924-8588, Ishikawa</wicri:regionArea>
<wicri:noRegion>Ishikawa</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Minami, Satoshi" sort="Minami, Satoshi" uniqKey="Minami S" first="Satoshi" last="Minami">Satoshi Minami</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pediatrics, Public Central Hospital of Matto Ishikawa, 3-8 Kuramitsu, Hakusan, 924-8588, Ishikawa, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Pediatrics, Public Central Hospital of Matto Ishikawa, 3-8 Kuramitsu, Hakusan, 924-8588, Ishikawa</wicri:regionArea>
<wicri:noRegion>Ishikawa</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Akimoto, Manabu" sort="Akimoto, Manabu" uniqKey="Akimoto M" first="Manabu" last="Akimoto">Manabu Akimoto</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Radiology, Public Central Hospital of Matto Ishikawa, Hakusan, Ishikawa, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Radiology, Public Central Hospital of Matto Ishikawa, Hakusan, Ishikawa</wicri:regionArea>
<wicri:noRegion>Ishikawa</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27836006</idno>
<idno type="pmid">27836006</idno>
<idno type="doi">10.1186/s12879-016-1985-1</idno>
<idno type="wicri:Area/PubMed/Corpus">000E96</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000E96</idno>
<idno type="wicri:Area/PubMed/Curation">000E96</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000E96</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000F67</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000F67</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Mycoplasma pneumoniae-associated mild encephalitis/encephalopathy with a reversible splenial lesion: report of two pediatric cases and a comprehensive literature review.</title>
<author>
<name sortKey="Ueda, Norishi" sort="Ueda, Norishi" uniqKey="Ueda N" first="Norishi" last="Ueda">Norishi Ueda</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pediatrics, Public Central Hospital of Matto Ishikawa, 3-8 Kuramitsu, Hakusan, 924-8588, Ishikawa, Japan. nueda@mattohp.com.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Pediatrics, Public Central Hospital of Matto Ishikawa, 3-8 Kuramitsu, Hakusan, 924-8588, Ishikawa</wicri:regionArea>
<wicri:noRegion>Ishikawa</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Minami, Satoshi" sort="Minami, Satoshi" uniqKey="Minami S" first="Satoshi" last="Minami">Satoshi Minami</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pediatrics, Public Central Hospital of Matto Ishikawa, 3-8 Kuramitsu, Hakusan, 924-8588, Ishikawa, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Pediatrics, Public Central Hospital of Matto Ishikawa, 3-8 Kuramitsu, Hakusan, 924-8588, Ishikawa</wicri:regionArea>
<wicri:noRegion>Ishikawa</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Akimoto, Manabu" sort="Akimoto, Manabu" uniqKey="Akimoto M" first="Manabu" last="Akimoto">Manabu Akimoto</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Radiology, Public Central Hospital of Matto Ishikawa, Hakusan, Ishikawa, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Radiology, Public Central Hospital of Matto Ishikawa, Hakusan, Ishikawa</wicri:regionArea>
<wicri:noRegion>Ishikawa</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">BMC infectious diseases</title>
<idno type="eISSN">1471-2334</idno>
<imprint>
<date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent</term>
<term>Brain Diseases (microbiology)</term>
<term>Brain Diseases (pathology)</term>
<term>Child</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Mycoplasma Infections (microbiology)</term>
<term>Mycoplasma Infections (pathology)</term>
<term>Mycoplasma pneumoniae</term>
<term>Spinal Cord Diseases (microbiology)</term>
<term>Spinal Cord Diseases (pathology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adolescent</term>
<term>Encéphalopathies (anatomopathologie)</term>
<term>Encéphalopathies (microbiologie)</term>
<term>Enfant</term>
<term>Femelle</term>
<term>Humains</term>
<term>Infections à Mycoplasma (anatomopathologie)</term>
<term>Infections à Mycoplasma (microbiologie)</term>
<term>Maladies de la moelle épinière (anatomopathologie)</term>
<term>Maladies de la moelle épinière (microbiologie)</term>
<term>Mycoplasma pneumoniae</term>
<term>Mâle</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Encéphalopathies</term>
<term>Infections à Mycoplasma</term>
<term>Maladies de la moelle épinière</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr">
<term>Encéphalopathies</term>
<term>Infections à Mycoplasma</term>
<term>Maladies de la moelle épinière</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiology" xml:lang="en">
<term>Brain Diseases</term>
<term>Mycoplasma Infections</term>
<term>Spinal Cord Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Brain Diseases</term>
<term>Mycoplasma Infections</term>
<term>Spinal Cord Diseases</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Child</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Mycoplasma pneumoniae</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adolescent</term>
<term>Enfant</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mycoplasma pneumoniae</term>
<term>Mâle</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">No literature review exists on Mycoplasma pneumoniae-associated mild encephalitis/encepharopathy with a reversible splenial lesion (MERS).</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
<PMID Version="1">27836006</PMID>
<DateCompleted>
<Year>2017</Year>
<Month>05</Month>
<Day>15</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>12</Month>
<Day>02</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">1471-2334</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>16</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2016</Year>
<Month>Nov</Month>
<Day>11</Day>
</PubDate>
</JournalIssue>
<Title>BMC infectious diseases</Title>
<ISOAbbreviation>BMC Infect. Dis.</ISOAbbreviation>
</Journal>
<ArticleTitle>Mycoplasma pneumoniae-associated mild encephalitis/encephalopathy with a reversible splenial lesion: report of two pediatric cases and a comprehensive literature review.</ArticleTitle>
<Pagination>
<MedlinePgn>671</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">No literature review exists on Mycoplasma pneumoniae-associated mild encephalitis/encepharopathy with a reversible splenial lesion (MERS).</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">M.pneumoniae-associated MERS cases were searched till August 2016 using PubMed/Google for English/other-language publications and Ichushi ( http://www.jamas.or.jp/ ) for Japanese-language publications. Inclusion criteria were children fulfilling definition for encephalitis, M.pneumoniae infection, and neuroimaging showing hyperintensity in the splenium of the corpus callosum (SCC) alone (type I) or SCC/other brain areas (type II).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">We described two children with type I and II M.pneumoniae-associated MERS. Thirteen cases found by the search and our 2 cases were reviewed. Mean age, male/female ratio, duration of prodromal illness was 8.3 years, 1.5 and 3.5 days. The most common neurological symptom was drowsiness, followed by abnormal speech/behavior, ataxia, seizure, delirium, confusion, tremor, hallucination, irritability, muscle weakness, and facial nerve paralysis. Fever was the most common non-neurological symptom, followed by cough, headache, gastrointestinal symptoms, headache, lethargy and dizziness. Seizure and respiratory symptoms were less common. All were diagnosed for M.pneumoniae by serology. Cerebrospinal fluid (CSF) M.pneumoniae was undetectable by PCR in the 3 patients. Three patients were clarithromycin-resistant. Leukocytosis, positive C-reactive protein, hyponatremia, CSF pleocytosis and slow wave on electroencephalography frequently occurred. All except 2 were type I MERS. Neuroimaging abnormalities disappeared within 18 days in the majority of patients. All type I patients completely recovered within 19 days. Two type II patients developed neurological sequelae, which recovered 2 and 6 months after onset.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Prognosis of M.pneumoniae-associated MERS is excellent. Type II MERS may increase a risk of neurological sequelae.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ueda</LastName>
<ForeName>Norishi</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatrics, Public Central Hospital of Matto Ishikawa, 3-8 Kuramitsu, Hakusan, 924-8588, Ishikawa, Japan. nueda@mattohp.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Minami</LastName>
<ForeName>Satoshi</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatrics, Public Central Hospital of Matto Ishikawa, 3-8 Kuramitsu, Hakusan, 924-8588, Ishikawa, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Akimoto</LastName>
<ForeName>Manabu</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Public Central Hospital of Matto Ishikawa, Hakusan, Ishikawa, Japan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2016</Year>
<Month>11</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>BMC Infect Dis</MedlineTA>
<NlmUniqueID>100968551</NlmUniqueID>
<ISSNLinking>1471-2334</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001927" MajorTopicYN="N">Brain Diseases</DescriptorName>
<QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009175" MajorTopicYN="N">Mycoplasma Infections</DescriptorName>
<QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009177" MajorTopicYN="Y">Mycoplasma pneumoniae</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013118" MajorTopicYN="N">Spinal Cord Diseases</DescriptorName>
<QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">Encephalitis</Keyword>
<Keyword MajorTopicYN="Y">MERS</Keyword>
<Keyword MajorTopicYN="Y">Mycoplasma pneumoniae</Keyword>
<Keyword MajorTopicYN="Y">Neuroimaging</Keyword>
<Keyword MajorTopicYN="Y">Splenium of the corpus callosum</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2016</Year>
<Month>07</Month>
<Day>01</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2016</Year>
<Month>10</Month>
<Day>27</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2016</Year>
<Month>11</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2016</Year>
<Month>11</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2017</Year>
<Month>5</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">27836006</ArticleId>
<ArticleId IdType="doi">10.1186/s12879-016-1985-1</ArticleId>
<ArticleId IdType="pii">10.1186/s12879-016-1985-1</ArticleId>
<ArticleId IdType="pmc">PMC5106775</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>J Microbiol Immunol Infect. 2014 Apr;47(2):137-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23726653</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Infect Dis. 2016 May 26;16:230</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27230114</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurol Sci. 2015 Nov;36(11):2043-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26130145</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2014 Sep 04;9(9):e106521</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25188448</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Dev. 2009 Aug;31(7):521-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19339128</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Dev. 2012 Feb;34(2):124-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21576007</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Exp Ther Med. 2015 Dec;10(6):2337-2344</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26668638</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Paediatr Neurol. 2015 May;19(3):377-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25707871</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Korean J Pediatr. 2014 Apr;57(4):186-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24868216</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatr Neurol. 2013 Feb;48(2):135-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23337007</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Microbiol Immunol Infect. 2014 Dec;47(6):497-502</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23968755</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Res. 1980 Nov 3;200(2):474-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7417825</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Swiss Med Wkly. 2016 Jan 11;146:w14222</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26752230</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurosci Res. 2013 Feb;91(2):240-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23161705</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Microbiol Immunol Infect. 2002 Sep;35(3):173-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12380790</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Chemother. 2007 Aug;13(4):204-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17721681</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Infect Dis. 2015 Oct 24;15:446</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26499987</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Psychiatr Res. 2015 Apr;63:132-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25748751</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurol Med Chir (Tokyo). 2010;50(12):1118-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21206192</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatrics. 2007 Aug;120(2):305-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17671056</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Intern Med. 2012;51(12):1647-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22728511</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Child Neurol. 2004 Nov;19(11):865-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15658791</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2001 Jun 15;32(12 ):1674-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11360206</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Dev. 2015 Jun;37(6):618-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25277296</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Epilepsia. 2011 Nov;52(11):1979-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21838790</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Clin Microbiol Infect Dis. 2009 Dec;28(12):1421-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19718525</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuroradiology. 2007 Jul;49(7):541-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17522852</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antimicrob Agents Chemother. 2014;58(2):1034-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24277047</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 1998 Feb;26(2):398-409</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9502462</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Microbiol. 2016 Feb 16;7:157</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26909073</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Dev. 2014 Apr;36(4):330-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23790266</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Dev. 2016 Nov;38(10 ):915-927</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27591118</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Adv Exp Med Biol. 2011;719:47-57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22125034</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Dev. 2009 Mar;31(3):217-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18490123</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neural Plast. 2013;2013:639430</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23577273</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatrics. 2015 Apr;135(4):e974-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25802349</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2015 Oct 1;61(7):1092-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26084846</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurology. 2004 Nov 23;63(10):1854-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15557501</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Exp Neurol. 2002 Dec;178(2):194-206</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12504879</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Japon</li>
</country>
</list>
<tree>
<country name="Japon">
<noRegion>
<name sortKey="Ueda, Norishi" sort="Ueda, Norishi" uniqKey="Ueda N" first="Norishi" last="Ueda">Norishi Ueda</name>
</noRegion>
<name sortKey="Akimoto, Manabu" sort="Akimoto, Manabu" uniqKey="Akimoto M" first="Manabu" last="Akimoto">Manabu Akimoto</name>
<name sortKey="Minami, Satoshi" sort="Minami, Satoshi" uniqKey="Minami S" first="Satoshi" last="Minami">Satoshi Minami</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F67 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000F67 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:27836006
   |texte=   Mycoplasma pneumoniae-associated mild encephalitis/encephalopathy with a reversible splenial lesion: report of two pediatric cases and a comprehensive literature review.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:27836006" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021